logoTry Persana

Acclinate - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Acclinate including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Acclinate company logo

Empowering Communities to Take Actions for Better Health

Acclinate is a digital health company focused on diversifying clinical trials and empowering underrepresented communities for better health outcomes.

HeadquartersBirmingham, United States
Team size51-100
Founded2020

What is Acclinate? - Company Overview & Details

Acclinate is Acclinate is a digital health company focused on diversifying clinical trials and empowering underrepresented communities for better health outcomes. Founded in 2020, the company is headquartered in Birmingham, United States.

Who Founded Acclinate?

Acclinate was founded by Del Smith, PhD, Tiffany Whitlow.

Who are the Key Executives at Acclinate? - Leadership Team

Acclinate is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Acclinate

Del Smith, PhDCEO

About Del Smith, PhD - CEO of Acclinate

Del Smith, PhD serves as the Chief Executive Officer of Acclinate, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Acclinate Company Details & Key Information

Where is Acclinate located?

Acclinate is headquartered in Birmingham, United States.

How many employees does Acclinate have?

Acclinate has 51-100 employees.

When was Acclinate founded?

Acclinate was founded in 2020.

Acclinate Official Website

How much funding has Acclinate raised?

Acclinate has raised $7 Million across 2 funding rounds. The most recent funding was completed on 2024-06-07.

Funding Overview

Acclinate raised $7 Million in Series A funding to enhance clinical trial diversity and health equity.

$7 Million
Total Funding Raised
2
Funding Rounds
2024-06-07
Latest Round

Acclinate Funding History

Series A
2024-06-07
$7 Million
Series unknown
2022-11-19
$4.9 Million

Who are the key investors in Acclinate?

Acclinate is backed by 1 key investors including Cencora Ventures. These investors focus on Health equity, Clinical trial diversity sectors.

Acclinate Investor Overview

1
Key Investors
2
Focus Areas
1
Notable Investments

Complete List of Acclinate Investors

Cencora Ventures

A corporate venture fund investing in emerging healthcare startups.

Investment Focus
Health equity
Clinical trial diversity
Notable Portfolio Companies
Acclinate

What sectors do Acclinate investors focus on?

The investors backing Acclinate primarily focus on Health equity, Clinical trial diversity sectors.

Health equity
Clinical trial diversity

Featured Investor: Cencora Ventures

Cencora Ventures

A corporate venture fund investing in emerging healthcare startups.

Notable Investments: Acclinate

What are Acclinate's future plans?

Acclinate Acclinate aims to expand its operations and partnerships to increase health equity.

Acclinate Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Acclinate face?

Acclinate has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Acclinate

1

Engaging underrepresented communities

2

Maintaining funding for initiatives

What opportunities does Acclinate have?

Acclinate has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Acclinate

1

Expanding partnerships

2

Increased focus on health equity in clinical trials

Acclinate Strategic Position Summary

Key Focus Areas

Acclinate is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Acclinate?

Acclinate has 2 recent news updates covering key business developments and market activities.

Acclinate News Overview

2
Recent Articles
Active
Media Coverage
2024-09-19
Latest Update

What is Acclinate in the news for?

Acclinate is currently featured in news for Acclinate Inc recognized as 2024 Fast Company Best Workplace for Innovators and other significant business developments.

Recent News Articles About Acclinate

Article 1
2024-09-19

Acclinate Inc recognized as 2024 Fast Company Best Workplace for Innovators

On Wednesday, Acclinate was recognized as a 2024 Fast Company Best Workplace for Innovators.

innovatealabama.org
Read News
Article 2
2024-08-13

Acclinate Inc recognized as No. 539 on the 2024 Inc. 5000

Acclinate ranks No. 539 on the 2024 Inc. 5000 list, highlighting its growth and commitment to diversifying clinical trials.

yahoo.com
Read News

Acclinate FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Acclinate including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Acclinate Questions & Answers - Company Information

Q1

What is Acclinate?

Acclinate is a digital health company focused on diversifying clinical trials and empowering underrepresented communities for better health outcomes.

Q2

Who founded Acclinate?

Acclinate was founded by Del Smith, PhD, Tiffany Whitlow.

Q3

Who is the CEO of Acclinate?

The CEO of Acclinate is Del Smith, PhD. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Acclinate raised?

Acclinate has raised a total of $$7 Million across 2 funding rounds. The most recent funding was completed on 2024-06-07.

Q5

Who are the investors in Acclinate?

Acclinate's key investors include Cencora Ventures.

Q6

Where is Acclinate headquartered?

Acclinate is headquartered in Birmingham, United States.

Q7

When was Acclinate founded?

Acclinate was founded in 2020.

Q8

How many employees does Acclinate have?

Acclinate has 51-100 employees.

Q9

What is Acclinate's official website?

You can visit Acclinate's official website at acclinate.com.

Q10

What was Acclinate's latest funding round?

Acclinate's latest funding round was a Series A round of $$7 Million completed on 2024-06-07.

Q11

Who is founder?

Del Smith, PhD

Q12

What does the company do?

Acclinate focuses on diversifying clinical trials and empowering underrepresented communities for better health outcomes.

Q13

How much funding?

$7 Million

Q14

Latest funding date?

2024-06-07

Q15

Who are the investors?

Cencora Ventures

Q16

What are the challenges?

Engaging underrepresented communities Maintaining funding for initiatives

Q17

What are the opportunities?

Expanding partnerships Increased focus on health equity in clinical trials

Q18

Latest news?

On Wednesday, Acclinate was recognized as a 2024 Fast Company Best Workplace for Innovators. Acclinate ranks No. 539 on the 2024 Inc. 5000 list, highlighting its growth and commitment to diversifying clinical trials.

More Information About Acclinate

For additional details about Acclinate, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.